| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790486 | American Journal of Ophthalmology | 2018 | 27 Pages |
Abstract
Overall, MGV354 0.1% demonstrated no statistically significant effect compared to vehicle in lowering IOP based on the study's main outcome measure. MGV354 produced ocular hyperemia consistent with its pharmacology.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Rebecca Stacy, Kenneth Huttner, Jen Watts, James Peace, David Wirta, Tom Walters, Kenneth Sall, John Seaman, Xiao Ni, Ganesh Prasanna, Muneto Mogi, Christopher Adams, Jing-He Yan, Michael Wald, Yunsheng He, Ronald Newton, Randall Kolega,